“Effectiveness and Safety of Palbociclib and Ribociclib As Treatment for Metastatic Breast Cancer in a Costa Rican Hospital from 2017 to 2022: Palbociclib Y Ribociclib En cáncer De Mama”. 2025. Acta Médica Costarricense 66 (4): 1-9. https://doi.org/10.51481/amc.v66i4.1434.